Opsens releases Q3 results
3 July 2014Quebec City, Quebec, July 3, 2014 – Opsens Inc. (“Opsens” or the “Company”) (TSXV:OPS) today released results for its third quarter ended May 31, 2014. HIGHLIGHTS First-in-human study well underway with 18 cases completed; Preparing for FFR product regulatory clearance for US, European and Canadian markets; Progressing towards gaining regulatory approval in Japan for the…